DIN 02526115 — REZUROCK 200 MG
REZUROCK is a tablet of Belumosudil marketed by SANOFI-AVENTIS CANADA INC. The full Belumosudil monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02526115
- Brand name
- REZUROCK
- Active ingredient
- Belumosudil
- Strength
- 200 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- SANOFI-AVENTIS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- ROCK2 inhibitor (protein kinase inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.